T1	Participants 43 70	patients with heart failure
T2	Participants 244 335	patients with heart failure (HF) due to reduced left ventricular ejection fraction (HFREF).
T3	Participants 418 434	those with HFREF
T4	Participants 628 652	2331 patients with HFREF
T5	Participants 654 776	Patients with New York Heart Association class II to IV HF and left ventricular ejection fractions of â‰¤ 35% were recruited
T6	Participants 1152 1310	Hemoglobin was available at baseline in 1763 subjects (76% of total study population); their median age was 59.0 years, 73% were male, and 62% were Caucasian.
T7	Participants 2875 2903	patients with chronic HFREF.
